AMPH vs CL · P/E 12, rev $732.0M vs P/E 34, rev $20.38B
Amphastar P (AMPH) versus Colgate-Palmolive Company (CL) — a side-by-side from cached financials, not a winner call.
Amphastar P (AMPH) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Colgate-Palmolive Company (CL) is a household & personal products company listed on US.
Latest reported AMPH revenue for 2024-12-31 was $732.0M. Net income was $159.5M. Revenue was up 13.6% from 2023-12-31 to 2024-12-31. AMPH currently screens at market cap $880.1M and trailing P/E 12.0.
Latest reported CL revenue for 2025-12-31 was $20.38B. Net income was $2.13B. Revenue was up 1.4% from 2024-12-31 to 2025-12-31. CL currently screens at market cap $70.88B and trailing P/E 34.3.
AMPH currently screens at market cap $880.1M and trailing P/E 12.0. CL currently screens at market cap $70.88B and trailing P/E 34.3.
Not investment advice. Open the AMPH and CL stock pages for the full models.
Not investment advice.